GlassScriptPhysician profile
Barbara Vinci
NPI 1528487543
$10,393.03
in general payments reported to CMS, 2019-2025
37 companies · $2,474 in 2025
The $2,474 reported for 2025 was more than what 81% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $1,449 · 2021: $559 · 2022: $1,944 · 2023: $1,659 · 2024: $1,883 · 2025: $2,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,680 · Education: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,680.00 |
| Education | $335.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,691.34 | 2019-2025 | |
| Janssen Biotech, INC. | $1,526.84 | 2019-2025 | Tremfya, Simponi, Stelara |
| Pfizer INC. | $676.38 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $580.76 | 2019-2025 | Odomzo, Blu-U, Ilumya |
| Genzyme Corporation | $495.49 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $477.05 | 2020-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $437.99 | 2019-2024 | |
| Arcutis Biotherapeutics, INC. | $405.49 | 2023-2025 | Zoryve |
| Lilly USA, LLC | $364.19 | 2019-2024 | Taltz |
| Mayne Pharma Commercial LLC | $346.98 | 2019-2025 | |
| Ucb, INC. | $335.95 | 2020-2025 | Bimzelx |
| Incyte Corporation | $325.32 | 2021-2025 | Opzelura |
| Dermavant Sciences, INC. | $313.54 | 2022-2024 | Vtama |
| Galderma Laboratories, L.P. | $290.26 | 2019-2024 | |
| Amgen INC. | $220.12 | 2022-2025 | Otezla, Otezla |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Vinci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.